Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suncare Traders' board, on February 3, 2026, approved unaudited financial results for Q3 FY26 (quarter ended Dec 31, 2025) and the nine months ended Dec 31, 2025. Total income for Q3 FY26 was just Rs. 29.97 lacs versus Rs. 261.86 lacs in Q3 FY25, and 9M FY26 income came in at Rs. 217.76 lacs versus Rs. 471.05 lacs in 9M FY25, showing a sharp year-on-year decline. Q3 FY26 profit after tax was Rs. 28.33 lacs against a prior-year quarter loss of Rs. 111.90 lacs, which had been pulled down by a one-time exceptional item of Rs. 185.62 lacs. Nine-month PAT jumped about 149% YoY to Rs. 198.08 lacs (from Rs. 79.47 lacs), largely because the base period absorbed that exceptional hit. EPS for 9M FY26 stood at Rs. 0.39 versus Rs. 0.16 earlier. Other equity remains negative at Rs. (1,070.08) lacs as of March 31, 2025, pointing to accumulated losses. Auditor M/s Goenka Mehta & Associates issued an unqualified limited review report.
The headline PAT growth flatters the picture because it benefits from the absence of last year's exceptional loss, while underlying revenue has actually collapsed on both a quarterly and year-to-date basis. Persistent negative other equity and a shrinking top line are red flags that could keep sentiment weak despite the reported profit.